Talk:Lonafarnib
Appearance
This is the talk page for discussing improvements to the Lonafarnib article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lonafarnib.
|
Sarasar
[edit]Doesn't lonafarnib go by the brand name Sarasar for the possible treatment of lung cancer? --74.179.122.10 (talk) 04:01, 25 January 2012 (UTC)
citation hepatitis D
[edit]Citation no 5 and 8 are the same citation, both for hepatitis D. Can someone help to make them a single citation? Psixtras (talk) 20:17, 23 August 2024 (UTC)
- I went ahead and made them the same citation. In the future, using ref names is the easiest way to do this. I personally use the tool Citer to create my citations which does this automatically. CursedWithTheAbilityToDoTheMath (talk) 21:38, 23 August 2024 (UTC)
Categories:
- Start-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages
- Stub-Class articles with conflicting quality ratings
- Stub-Class chemicals articles
- Low-importance chemicals articles